{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:38:13Z","timestamp":1779151093903,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"FAPERJ","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bioorg.2021.105250","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T13:50:58Z","timestamp":1628689858000},"page":"105250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Synthesis and in vitro and in silico studies of 1H- and 2H-1,2,3-triazoles as antichagasic agents"],"prefix":"10.1016","volume":"116","author":[{"given":"Thais B.","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathya N.K.","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Petzold Pauli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00edssa M.S.","family":"Galv\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana F.M.","family":"Faria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murilo L.","family":"Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackson A.L.C.","family":"Resende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinicius R.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luana da S.M.","family":"Forezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando de C.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robson X.","family":"Faria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitor F.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2021.105250_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/14756360903524304","article-title":"Pharmacological significance of triazole scaffold","volume":"26","author":"Kharb","year":"2011","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2021.105250_b0010","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.bmc.2019.07.005","article-title":"1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: a recent overview","volume":"27","author":"Bozorov","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105250_b0015","doi-asserted-by":"crossref","unstructured":"W. Dehaen, V.A. Bakulev, Chemistry of 1,2,3-triazoles in Topics in Heterocyclic Chemistry, (Eds.), Springer, Switzerland, 2015.","DOI":"10.1007\/978-3-319-07962-2"},{"issue":"3","key":"10.1016\/j.bioorg.2021.105250_b0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0168-6445(99)00039-X","article-title":"Molecular basis of antibiotic resistance and \u03b2-lactamase inhibition by mechanism-based inactivators: perspectives and future directions","volume":"24","author":"Therrien","year":"2000","journal-title":"FEMS Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105250_b0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/jac\/dkv362","article-title":"Impact of the MIC of piperacillin\/tazobactam on the outcomefor patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project","volume":"71","author":"Delgado-Valverde","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105250_b0030","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1517\/13543784.2014.930127","article-title":"Cephalosporins currently in early clinical trials for the treatment of bacterial infections","volume":"23","author":"Long","year":"2014","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"2","key":"10.1016\/j.bioorg.2021.105250_b0035","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1128\/AAC.10.2.288","article-title":"In vitro evaluation of the new oral cephalosporin cefatrizine: comparison with other cephalosporins","volume":"10","author":"Blackwell","year":"1976","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.bioorg.2021.105250_b0040","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1517\/14656566.8.12.1931","article-title":"Rufinamide: a new anti-epileptic medication","volume":"8","author":"Hakimian","year":"2007","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bioorg.2021.105250_b0045","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1528-1167.2009.02160.x","article-title":"Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial","volume":"50","author":"Brodie","year":"2009","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.bioorg.2021.105250_b0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1586\/ern.09.136","article-title":"Drug interactions involving the new second- and third-generation antiepileptic drugs","volume":"10","author":"Johannessen Landmark","year":"2010","journal-title":"Expert Rev. Neurother."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105250_b0055","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/13543776.2013.749862","article-title":"Novel 1H\u20131,2,3-, 2H\u20131,2,3-, 1H\u20131,2,4- and 4H\u20131,2,4-triazole derivatives: a patent review (2008\u20132011)","volume":"23","author":"Ferreira","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2021.105250_b0060","doi-asserted-by":"crossref","unstructured":"F.C. da Silva, M.F.C. Cardoso, P.G. Ferreira, V.F. Ferreira, Biological properties of 1H-1,2,3- and 2H-1,2,3-triazole in: W. Dehaen, V.A. Bakulev (Eds.), Chemistry of 1,2,3-triazoles. Topics in Heterocyclic Chemistry, vol. 40, Springer, Cham., 2015, pp. 117\u2013166. doi: 10.1007\/7081_2014_124.","DOI":"10.1007\/7081_2014_124"},{"issue":"13","key":"10.1016\/j.bioorg.2021.105250_b0065","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ange.19630751304","article-title":"1.3-Dipolare cycloadditionen r\u00fcckschau und ausblick","volume":"75","author":"Huisgen","year":"1963","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2021.105250_b0070","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/anie.196306331","article-title":"Kinetics and mechanism of 1,3-dipolar cycloadditions","volume":"2","author":"Huisgen","year":"1963","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2021.105250_b0075","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/1521-3757(20010601)113:11<2056::AID-ANGE2056>3.0.CO;2-W","article-title":"Click-Chemie: diverse chemische Funktionalit\u00e4t mit einer Handvoll guter Reaktionen","volume":"113","author":"Kolb","year":"2001","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2021.105250_b0080","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","article-title":"Click chemistry: diverse chemical function from a few good reactions","volume":"40","author":"Kolb","year":"2001","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2021.105250_b0085","first-page":"7","article-title":"Catalytic azide-alkyne cycloaddition: reactivity and applications","volume":"40","author":"Wu","year":"2007","journal-title":"Aldrichim. Acta"},{"key":"10.1016\/j.bioorg.2021.105250_b0090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/092986712803414213","article-title":"Recent researches in triazole compounds as medicinal drugs","volume":"19","author":"Zhou","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2021.105250_b0095","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1359-6446(03)02933-7","article-title":"The growing impact of click chemistry on drug discovery","volume":"8","author":"Kolb","year":"2003","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2021.105250_b0100","first-page":"481","article-title":"Recent advances of 1, 2, 3-triazole compounds in medicinal chemistry","volume":"46","author":"Wei","year":"2011","journal-title":"J. Chin. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2021.105250_b0105","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2174\/1568026618666180821143902","article-title":"Alternative routes to the click method for the synthesis of 1,2,3-triazoles, an important heterocycle","volume":"18","author":"Forezi","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105250_b0110","article-title":"Bioactive 1,2,3-triazoles: an account on their synthesis, structural diversity and biological applications","volume":"21","author":"Forezi","year":"2021","journal-title":"Chem. Rec."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105250_b0115","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/cbdd.13333","article-title":"New 1,2,3-triazole-based analogues of benznidazole for use against Trypanosoma cruzi infection: In vitro and in vivo evaluations","volume":"92","author":"Leite","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2021.105250_b0120","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1590\/S0103-50532009000400007","article-title":"Cytotoxic, trypanocidal activities and physicochemical parameters of nor-\u03b2-lapachone-based 1,2,3-triazoles","volume":"20","author":"Silva-Jr","year":"2009","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.bioorg.2021.105250_b0125","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.1021\/acs.jmedchem.7b00463","article-title":"Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi","volume":"60","author":"Brand","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105250_b0130","first-page":"1217","article-title":"Synthesis and antitrypanosomastid activity of 1,4-diaryl-1,2,3-triazole analogues of neolignans veraguensin, grandisin and machilin G","volume":"27","author":"Cassamale","year":"2016","journal-title":"J. Braz. Chem. Soc."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105250_b0135","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2174\/1573406414666180912120502","article-title":"Synthesis of new thiosemicarbazones and semicarbazones containing the 1,2,3\u20131H-triazole-isatin scaffold: trypanocidal, cytotoxicity, electrochemical assays, and molecular docking","volume":"15","author":"Silva","year":"2019","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105250_b0140","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/cbdd.13628","article-title":"Synthesis, activity, and molecular modeling studies of 1,2,3-triazole derivatives from natural phenylpropanoids as new trypanocidal agents","volume":"95","author":"Souza","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"issue":"5","key":"10.1016\/j.bioorg.2021.105250_b0145","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1039\/C7MD00008A","article-title":"Antitrypanosomal and antileishmanial activity of prenyl-1,2,3-triazoles","volume":"8","author":"Porta","year":"2017","journal-title":"MedChemComm"},{"issue":"2","key":"10.1016\/j.bioorg.2021.105250_b0150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10863-018-9746-z","article-title":"Searching for new drugs for Chagas diseases: triazole analogs display high in vitro activity against Trypanosoma cruzi and low toxicity toward mammalian cells","volume":"50","author":"Faria","year":"2018","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bioorg.2021.105250_b0155","doi-asserted-by":"crossref","unstructured":"O. Dimroth, Ueber intramolekulare Umlagerungen. Umlagerungen in der Reihe des 1, 2, 3-Triazols. Justus Liebigs Ann. Chem. 364 (1909) 183\u2013226. doi: 10.1002\/jlac.19093640204un.","DOI":"10.1002\/jlac.19093640204"},{"issue":"1","key":"10.1016\/j.bioorg.2021.105250_b0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jlac.19274590104","article-title":"Intramolekulare Umlagerung der 5-Amino-1,2,3-triazole","volume":"459","author":"Dimroth","year":"1927","journal-title":"Justus Liebigs Ann. Chem."},{"key":"10.1016\/j.bioorg.2021.105250_b0165","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.2174\/1385272824999200805114837","article-title":"Dimroth\u0301s rearrangement as a synthetic strategy towards new heterocyclic compounds","volume":"24","author":"Ferreira","year":"2020","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.bioorg.2021.105250_b0170","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1021\/jo01357a018","article-title":"Synthesis and isomerization of substituted 5-amino-l,2,3-triazoles","volume":"22","author":"Lieber","year":"1957","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2021.105250_b0175","first-page":"3","article-title":"SHELXT\u2013Integrated space-group and crystal-structure determination","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. A C"},{"issue":"2","key":"10.1016\/j.bioorg.2021.105250_b0180","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1107\/S0021889808042726","article-title":"OLEX 2: a complete structure solution, refinement and analysis program","volume":"42","author":"Dolomanov","year":"2009","journal-title":"J. Appl. Cryst."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105250_b0185","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/jccs.200800114","article-title":"Synthesis of (3,5-aryl\/methyl-1H-pyrazol-1-yl)-(5-arylamino-2H-1,2,3-triazol-4-yl)methanone","volume":"55","author":"Cao","year":"2008","journal-title":"J. Chin. Chem. Soc."},{"key":"10.1016\/j.bioorg.2021.105250_b0190","first-page":"11","article-title":"Heterocyclic \u03b2-enamino esters 51. Carbon-13 NMR studies of the Dimroth rearrangement of 1,2,3-triazoles","volume":"113","author":"Wamhoff","year":"1989","journal-title":"Chemiker Zeitung"},{"key":"10.1016\/j.bioorg.2021.105250_b0195","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10870-008-9425-8","article-title":"The synthesis and Crystal Structure of 5-(4-bromophenylamino)-2-methylsulfanyl-2H-1,2,3-triazol-4-carboxylic acid Ethyl Ester","volume":"39","author":"Wang","year":"2009","journal-title":"J. Chem. Crystalogr."},{"key":"10.1016\/j.bioorg.2021.105250_b0200","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1371\/journal.pntd.0000372","article-title":"Trypanosoma cruzi CYP51 inhibitor derived from a mycobacterium tuberculosis screen hit","volume":"3","author":"Chen","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioorg.2021.105250_b0205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J. Cheminf."},{"key":"10.1016\/j.bioorg.2021.105250_b0210","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","article-title":"Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94","volume":"17","author":"Halgren","year":"1996","journal-title":"J. Comp. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2021.105250_b0215","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00894-007-0233-4","article-title":"Optimization of parameters for semiempirical methods V: Modification of NDDO approximations and application to 70 elements","volume":"13","author":"Stewart","year":"2007","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.bioorg.2021.105250_b0220","unstructured":"MOPAC2016, James J. P. Stewart, Stewart Computational Chemistry, Colorado Springs, CO, USA, HTTP:\/\/OpenMOPAC.net (2016)."},{"key":"10.1016\/j.bioorg.2021.105250_b0225","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/jm051197e","article-title":"MolDock: a new technique for high-accuracy molecular docking","volume":"49","author":"Thomsen","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105250_b0230","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/ijms17020144","article-title":"Insights into protein-ligand interactions: mechanisms, models, and methods","volume":"17","author":"Du","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2021.105250_b0235","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1039\/P29930000799","article-title":"COSMO, a new approach to dielectric screening in solvents with explicit expressions for the screening energy and its gradient","volume":"2","author":"Klamt","year":"1993","journal-title":"J. Chem. Soc., Perkin Trans."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105250_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00894-012-1667-x","article-title":"Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters","volume":"19","author":"Stewart","year":"2013","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.bioorg.2021.105250_b0245","doi-asserted-by":"crossref","unstructured":"N. Boechat, V.F. Ferreira, S.B. Ferreira, M.L.G. Ferreira, F.C. da Silva, M.M. Bastos, M.S. Costa, M.C.S. Louren\u00e7o, A.C. Pinto, A.U. Krettli, A.C. Aguiar, B.M. Teixeira, N.V. da Silva, P.R.C. Martins, F.A.F.M. Bezerra, A.L.S. Camilo, G.P. da Silva, C.C.P. Costa, Novel 1,2,3-Triazole Derivatives for Use against Mycobacterium tuberculosis H37Rv (ATCC 27294) Strain. J. Med. Chem. 54 (2011) 5988\u20135999. Doi: 10.1021\/jm2003624.","DOI":"10.1021\/jm2003624"},{"key":"10.1016\/j.bioorg.2021.105250_b0250","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ejmech.2017.08.034","article-title":"1-Aryl-1H- and 2-aryl-2H-1,2,3-triazole derivatives blockade P2X7 receptor in vitro and inflammatory response in vivo","volume":"139","author":"Gonzaga","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105250_b0255","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1039\/jr9530003820","article-title":"781. The Tautomerism of 5-Amino-1-aryl-l:2:3-triazoles","author":"Brown","year":"1953","journal-title":"J. Chem. Soc."},{"key":"10.1016\/j.bioorg.2021.105250_b0260","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/cber.19600930914","article-title":"Synthesis of nitrogen-containing heterocycles, XXIV. Preparation and ortho-condensation of some 4,5-disubstituted 1,2,3-triazoles","volume":"93","author":"Dornow","year":"1960","journal-title":"Chem. Ber."},{"key":"10.1016\/j.bioorg.2021.105250_b0265","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1021\/jo01357a018","article-title":"Synthesis and isomerization of substituted 5-amino-1,2,3-triazoles","volume":"22","author":"Lieber","year":"1957","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2021.105250_b0270","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/mrc.1260240914","article-title":"Heterocyclic \u03b2-enamino esters 43 - Easy \u201cC NMR distinction between aryl-substituted dimroth isomers of the 1,2,3-triazole series","volume":"24","author":"Wamhoff","year":"1986","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.bioorg.2021.105250_b0275","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1139\/v84-215","article-title":"Effect of substituents in the for mation of diacetanilides","volume":"62","author":"Ayyangar","year":"1984","journal-title":"Can. J. Chem."},{"key":"10.1016\/j.bioorg.2021.105250_b0280","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1107\/S0108270197009682","article-title":"Pyrrole and a Co-crystal of 1H- and 2H\u20131,2,3-Triazole","volume":"53","author":"Goddard","year":"1997","journal-title":"Acta Crystallogr. C"},{"key":"10.1016\/j.bioorg.2021.105250_b0285","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1002\/1099-0690(200108)2001:16<3013::AID-EJOC3013>3.0.CO;2-Y","article-title":"Basicity of N-H- and N-methyl-1,2,3-triazoles in the gas phase, in solution, and in the solid state \u2212 an experimental and theoretical study","author":"Abboud","year":"2001","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2021.105250_b0290","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2741\/1639","article-title":"Recent progress in the CYP51 research focusing on its unique evolutionary and functional characteristics as a diversozyme P450","volume":"10","author":"Aoyama","year":"2005","journal-title":"Front. Biosci."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105250_b0295","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0014-4894(89)90134-3","article-title":"Sterols of parasitic protozoa and helminths","volume":"68","author":"Furlong","year":"1989","journal-title":"Exp. Parasitol."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105250_b0300","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-6851(02)00280-3","article-title":"Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa","volume":"126","author":"Roberts","year":"2003","journal-title":"Mol. Biochem. Parasitol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821006271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821006271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:21:20Z","timestamp":1758615680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821006271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":60,"alternative-id":["S0045206821006271"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105250","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and in vitro and in silico studies of 1H- and 2H-1,2,3-triazoles as antichagasic agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105250"}}